SCHEMBL5087320

SCHEMBL5087320

CCCC[Si](C)(C)CNC(=O)CCS

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.41
CASP2 P42575 1/20 0.40
DNM1 Q05193 2/20 0.39
NAAA Q02083 1/20 0.38
HSP90AA1 P07900 1/20 0.34
CNR1 P21554 4/20 0.33
CNR2 P34972 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138168 0.95 FAAH (0.44) FAAHCASP2DNM1NAAAHSP90AA1
SCHEMBL5090713 0.93 FAAH (0.47) FAAHCASP2DNM1NAAAHSP90AA1
SCHEMBL5087390 0.93 FAAH (0.47) FAAHCASP2DNM1NAAAHSP90AA1
SCHEMBL5138320 0.91 FAAH (0.34) FAAHCASP2DNM1NAAAHDAC3
SCHEMBL6204263 0.76 CASP2 (0.61) FAAHCASP2DNM1NAAACNR1
SCHEMBL11912070 0.75 CASP2 (0.70) FAAHCASP2DNM1NAAACNR1
SCHEMBL29290542 0.73 CASP2 (0.74) FAAHCASP2DNM1NAAAEPHX2
SCHEMBL20683710 0.73 CASP2 (0.74) FAAHCASP2DNM1NAAAEPHX2
SCHEMBL21548098 0.73 CASP2 (0.74) FAAHCASP2DNM1NAAAEPHX2
SCHEMBL965531 0.73 CASP2 (0.74) FAAHCASP2DNM1NAAAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968609-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND Pharmaceuticals, Inc. (US) 2008-09-17 EP disclosed
WO-2007073560-A2 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS RND PHARMACEUTICALS, INC. (US) 2007-06-28 WO disclosed